WS
HELP

Wedbush Securities’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Wedbush Securities’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,724
Closed -$18K – 1136
2024
Q2 		$18K Sell
1,724
-26
-1% -$340 ﹤0.01% 1190
2024
Q1 		$27K Hold
1,750
– – ﹤0.01% 1221
2023
Q4 		$27K Hold
1,750
– – ﹤0.01% 1073
2023
Q3 		$35K Hold
1,750
– – ﹤0.01% 1035
2023
Q2 		$25K Sell
1,750
-79
-4% -$950 ﹤0.01% 1049
2023
Q1 		$27K Sell
1,829
-53
-3% -$859 ﹤0.01% 1055
2022
Q4 		$21K Hold
1,882
– – ﹤0.01% 1035
2022
Q3 		$35K Hold
1,882
– – ﹤0.01% 1023
2022
Q2 		$40K Buy
+1,882
New +$45.6K ﹤0.01% 1040
2022
Q1 		– Sell
-1,947
Closed -$89K – 1123
2021
Q4 		$89K Buy
1,947
+710
+57% +$45K ﹤0.01% 1133
2021
Q3 		$103K Buy
+1,237
New +$108K ﹤0.01% 1132

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Wedbush Securities's HELP Position: Q3 2024 in Review

Wedbush Securities sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 1,724 shares — an estimated $18K sold.

Wedbush Securities first reported a position in HELP in Q3 2021 and held it in 11 quarters. The position peaked at $103K in Q3 2021. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Wedbush Securities reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Wedbush Securities sold 1,724 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $18K.
  • Wedbush Securities first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Wedbush Securities's Helus Pharma Inc. Common Stock position peaked at $103K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Wedbush Securities's 13F filing for Q3 2024, filed 8 Nov 2024.